Sarcopenia is thought to be related to the microbiome, but not enough reports in chronic
liver disease (CLD) patients. In addition to the differences in microbiome, the role of the …

Background & Aims Sarcopenia and gut dysbiosis are common in individuals with cirrhosis.
However, the association between sarcopenia and microbial alterations, and the …

Objectives The intestinal microbiota plays an important role in the nutritional status and
energy metabolism of the host. Liver cirrhosis is accompanied by muscle wasting or …

Background Sarcopenia in liver cirrhosis is associated with low quality of life and high
mortality risk. The pathogenesis has yet to be fully understood. We hypothesized that gut …

Abstract Background & Aim Sarcopenia is frequent in cirrhosis and is associated with
unfavourable outcomes. The role of the gut‐liver‐muscle axis in this setting has been poorly …

Sarcopenia in patients with liver cirrhosis (LC) has been attracting much attention these
days because of the close linkage to adverse outcomes. LC can be related to secondary …

Sarcopenia is the loss of muscle mass and function, affecting up to 70% of patients with
advanced liver disease. Liver cirrhosis is characterized by an altered glucose metabolism …

Background Several studies have examined gut microbiota and sarcopenia using 16S
ribosomal RNA amplicon sequencing; however, this technique may not be able to identify …

Background Sarcopenia leads to complications (infections, hepatic encephalopathy and
ascites) and poor overall survival in patients with cirrhosis, in which the phenotypic …

Background The gut microbiota is a complex microbial community that changes in response
to various intestinal diseases, including aging-related diseases such as sarcopenia. Several …